Abstract
The high prevalence of use among offenders is a consistent trend that transcends international boundaries. Chronic drug users in the criminal justice system pose risks to themselves and the general population through their commission of drug-related property and violent crime, as well as through the spread of infectious diseases, such as HIV and HCV. In this chapter, we review multinational evidence concerning the drug/crime relationship, the use of drugs within correctional settings, the consequences of drug use among offenders, and the intervention approaches for drug-involved offenders in custodial settings as well as those under community supervision. We conclude with several recommendations for practice and research that we consider to be important next steps in advancing this literature: (1) focus on implementation; (2) need for more randomized trials; (3) clarification of the role of coercion – when it helps, when it hurts; (4) distinguish “addicted offenders” from “offender addicts”; and (5) examine the use of depot medications for opiate-dependent offenders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Asscher JJ, Deković M, van der Laan PH, Prins P, van Arum S (2007) Implementing randomized experiments in criminal justice settings: an evaluation of multi-systemic therapy in the Netherlands. J Exp Criminol 3:113–129
Bahr SJ, Masters AL, Taylor BM (2012) What works in substance abuse treatment programs for offenders? Prison J 92(2):155–174
Baillargeon J, Giordano TP, Rich J, Wu Z, Wells K, Pollack BH, Paar DP (2009) Accessing antiretroviral therapy following release from prison. JAMA 301(8):848–857
Bayanzadeh SA, Bolhari J, Noori R, Lavasani F, Karimi E (2007) The role of pharmacotherapeutic and psychosocial interventions in reducing drug related harm among addict prisoners. J Iran Univ Med Sci 14(55):47–55, [In Farsi] Cited in Momtazi S and Noroozi A (this volume)
Belenko S (1998) Research on drug courts: a critical review. Natl Drug Court Inst Rev 1(1):1–42
Betteridge G, Jurgens R (2008) Opioid substitution therapy in prisons: reviewing the evidence. Canadian HIV/AIDS Legal Network, Canada, http://www.aidslaw.ca/publications/interfaces/downloadFile.php?ref=1293. Accessed 1 May 2013
Bewley-Taylor D, Hallam C, Allen R (2009) The incarceration of drug offenders: an overview. King’s College, London
Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD (2007) Release from prison – a high risk of death for former inmates. New Engl J Med 356(2):157–165
Bullock T (2003) Changing levels of drug use before, during and after imprisonment. In: Ramsay M (ed) Prisoners’ drug use and treatment: seven research studies. Home office research study 267. Home Office, London, pp 23–49
Bureau of Justice Statistics (2002) Recidivism of prisoners released in 1994. GPO, Washington, DC
Cartier J, Farabee D, Prendergast ML (2006) Methamphetamine use, violence, and recidivism among California parolees. J Interpers Violence 21:435–445
Center on Addiction and Substance Abuse (CASA) (2010) Behind bars II: substance abuse in America’s prison population. CASA, New York
Cornish JW, Metzger D, Woody GE, Wilson D, McLellan AT, Vandergrift B, O’Brien CP (1997) Naltrexone pharmacotherapy for opioid dependent federal probationers. J Subst Abuse Treat 14:529–534
Dolan K, Khoei EM, Brentari C, Stevens A (2007) Prisons and drugs: a global review of incarceration, drug use, and drug services. Beckley Foundation, London
Farabee D, Prendergast ML, Cartier J, Wexler W, Knight K, Anglin MD (1999) Barriers to implementing effective correctional treatment programs. Prison J 79(2):150–162
Farnia M, Ebrahimi B, Shams A, Zamani S (2010) Scaling up methadone treatment for opioid-dependent prisoners in Iran. Int J Drug Policy 21:422–424
Farrell M, Marsden J (2007) Acute risk of drug-related death among newly released prisoners in England and Wales. Addiction 103:251–255
Farrington D, Welsh BC (2005) Randomized experiments in criminology: what have we learned in the past two decades? J Exp Criminol 1:9–38
Ferri M, Amato L, Davoli M (2006) Alcoholics anonymous and other 12-step programmes for alcohol dependence. Cochrane Database Syst Rev 3:CD005032, Wiley and Sons, London
Foster J, Brewer C, Steele T (2003) Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totaling 101 patients with a note on naltrexone blood levels. Addict Biol 8:211–217
Friedmann P, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LAR, Sacks S, O’Connell DJ, Knudsen HK, Shafer MS, Hall E, Frisman LK (2012) Medication-assisted treatment in criminal justice agencies affiliated with the Criminal Justice-Drug Abuse Treatment Studies (CJ-DATS): availability, barriers and intentions. Subst Abus 33:9–18
Gendreau P, Goggin C, Smith P (1999) The forgotten issue in effective correctional treatment: program implementation. Int J Offender Ther Comp Criminol 43(2):180–187
Gillespie W (2005) A multilevel model of drug abuse inside prison. Prison J 85(2):223–246
Goldstein PJ (1985) The drugs/violence nexus: a tripartite conceptual framework. J Drug Issues 15:493–506
Gordon MS, Kinlock TW, Schwartz RP, O’Grady KE (2008) A randomized clinical trial of methadone maintenance for prisoners: findings at 6-months post-release. Addiction 103:1333–1342
Gottfredson D, Exum L (2002) The Baltimore City drug court: one-year results from a randomized study. J Res Crime Delinq 39:337–356
Gottfredson DC, Kearley B, Najaka SS, Rocha C (2005) The Baltimore City drug treatment court: three-year self-report outcome study. Eval Rev 29(1):42–64
Hawken A, Kleiman M (2009) Managing drug-involved probationers with swift and certain sanctions: evaluating Hawaii’s HOPE. NCJ 229023. National Institute of Justice, Washington
Hough M (2002) Drug user treatment within a criminal justice context. Subst Use Misuse 37:985–996
Inciardi JA, Lockwood D, Quinlan JA (1993) Drug use in prison: patterns, processes, and implications for treatment. J Drug Issues 23(1):119–130
Kendall PRW, Pearce M (2000) Drug testing in Canadian jails: to what end? Can J Public Health 91(1):26–28
Krupitsky E, Nunes EV, Ling W, Illeperuma A, Gastfriend DR, Silverman BL (2011) Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial. Lancet 377:1506–1513
Landenberger NA, Lipsey MW (2005) The positive effects of cognitive-behavioral programs for offenders: a meta-analysis of factors associated with effective treatment. J Exp Criminol 1:451–476
Ling W, Wesson DR (2003) Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Drug Alcohol Depend 70(2):S49–S58
Magill M, Ray L (2009) Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs 70:516–527
Mattick RP, Kimber J, Breen C, Davoli M (2008) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2:CD002207
Merrall LC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, Hutchinson SJ, Bird SM (2010) Meta-analysis of drug-related deaths soon after release from prison. Addiction 105:1545–1554
Momtazi S, Rawson R, Musavinasab N, Hamzehlu MB (2012) Methadone maintenance treatment program for drug abuse prisoners in Iran. Abstract book of the National Institute on Drug Abuse international forum. Palm Springs, California
Mumola CJ, Karberg JC (2006) Drug use and dependence: state and federal prisoners, 2004. Office of Justice Programs, Bureau of Justice Statistics, Washington, DC
Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD (2009) Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 105:83–88
Nurco DN, Hanlon TE, Kinlock TW, Duszynski KR (1988) Differential criminal patterns of narcotic addicts over an addiction career. Criminology 26:407–423
Oser CB, Knudsen HK, Staton-Tindall M, Taxman F, Leukefeld C (2009) Organizational-level correlates of the provision of detoxification services and medication-based treatment for substance abuse in correctional institutions. Drug Alcohol Depend 103(Suppl 1):S73–S81
Payne J, Gaffney A (2012) How much crime is drug or alcohol related? Self reported attributions of police detainees. Trends & issues in crime and criminal justice 439 http://www.aic.gov.au/publications/current%20series/tandi/421-440/tandi439.html. Accessed 1 May 2013
Pearson FS, Lipton DS (1999) A meta-analytic review of the effectiveness of corrections-based treatments for drug abuse. Prison J 79(4):384–410
Pernanen K, Cousineau M, Brochu S, Sun F (2002) Proportions of crimes associated with alcohol and other drugs in Canada. Canadian Centre on Substance Abuse, Ottawa
Phipps P, Korinek K, Aos S, Lieb R (1999) Research findings on adult corrections programs: a review. Washington State Institute for Public Policy, Olympia
Shewan D, Gemmell M, Davies JB (1994) Prison as a modifier of drug using behavior. Addict Res Theory 2(2):203–215
Sokolov BP, Schindler CW, Cadet JL (2004) Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav 77:319–326
Stephenson BL, Wohl DA, Golin CE, Tien HC, Stewart P, Kaplan AH (2005) Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals. Public Health Rep 120(1):84–88
Stover H, Michels II (2010) Drug use and opioid substitution treatment for prisoners. Harm Reduction J 7:17–24
Tardiff K, Gross E, Messner S (1986) A study of homicide in Manhattan, 1081. Am J Public Health 76:139–143
Taxman F, Perdoni ML, Harrison L (2007) Drug treatment services for adult offenders: the state of the state. J Subst Abuse Treat 32:239–254
Vigdal GL, Stadler DW (1989) Controlling inmate drug use: cut consumption by reducing demand. Correct Today 51(3):96–97
Wild TC, Roberts AB, Cooper EL (2002) Compulsory substance abuse treatment: an overview of recent findings and issues. Eur Addict Res 8:84–93
Zurhold H, Stöver H, Haasen C (2004) Female drug users in European prisons – best practice for relapse prevention and reintegration. Centre for Interdisciplinary Addiction Research, University of Hamburg, Hamburg
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this entry
Cite this entry
Farabee, D., Rawson, R.A., Gawad, T.A. (2015). Treatment in Criminal Justice Settings. In: el-Guebaly, N., Carrà, G., Galanter, M. (eds) Textbook of Addiction Treatment: International Perspectives. Springer, Milano. https://doi.org/10.1007/978-88-470-5322-9_112
Download citation
DOI: https://doi.org/10.1007/978-88-470-5322-9_112
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5321-2
Online ISBN: 978-88-470-5322-9
eBook Packages: MedicineReference Module Medicine